Table 4.
Wtinitial | Wt−10% | Wtinitial | Wt+10% | |
---|---|---|---|---|
Weight, kg | 109.6±8.9 | 96.4±7.5* | 65.4±3.7 | 71.7±4.2† |
Height, cm | 170.7±2.0 | 167.1±7.2 | ||
BMI, kg/m2 | 36.1±2.5 | 31.1±2.2* | 23.6±1.1 | 24.5±0.8† |
Fat-free mass, kg | 63.5±3.6 | 59.8±3.4* | 54.7±3.8 | 56.9±4.3 |
Fat mass, kg | 45.4±5.7 | 35.2±4.8* | 10.6±2.2 | 14.8±2.2† |
Serum glucose, mmol/l | 4.88±0.12 | 4.72±0.13 | 4.55±0.11 | 4.49±0.12 |
Plasma insulin, pmol/l | 26.8±2.9 | 26.5±3.5 | 23.2±2.7 | 33.2±5.8 |
Plasma leptin, ng/ml | 34.1±6.8 | 22.4±5.9* | 5.5±3.4 | 7.6±3.4† |
Serum triiodothyronine, nmol/l | 1.45±0.07 | 1.23±0.04* | 1.51±0.08 | 1.62±0.10 |
Plasma adiponectin, μg/ml | 5.31±0.52 | 5.77±0.57* | 13.22±1.27 | 11.00±1.16† |
Means ± SE clinical and biochemical characteristics of subjects. Thirty subjects (18 obese, 7 never-obese; 12 males, 13 females) were studied at Wtinitial and Wt−10%. Five subjects (4 never-obese males; 1 never-obese female) were studied at Wtinitial and Wt+10%. BMI, body mass index.
P < 0.001 compared to Wtinitial;
P < 0.05 compared to Wtinitial.